Drug Shortage Report for CERETEC

Last updated on 2021-09-09 History
Report ID 143671
Drug Identification Number 02484048
Brand name CERETEC
Common or Proper name Kit for the Preparation of Technetium-99m Exametazime Injection
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) EXAMETAZIME
Strength(s) 0.5MG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 unit package
ATC code V09HA
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-08-05
Estimated end date 2021-09-10
Actual end date 2021-09-08
Shortage status Resolved
Updated date 2021-09-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-08-05 English Compare
v2 2021-08-05 French Compare
v3 2021-08-06 English Compare
v4 2021-08-18 English Compare
v5 2021-08-18 French Compare
v6 2021-08-19 English Compare
v7 2021-08-19 French Compare
v8 2021-09-03 English Compare
v9 2021-09-03 French Compare
v10 2021-09-08 English Compare
v11 2021-09-08 French Compare
v12 2021-09-09 English Compare

Showing 1 to 12 of 12